Alyeska Investment Group
BOLD

Alyeska Investment Group’s Boundless Bio BOLD Stock Holding History

Alyeska Investment Group’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$750K Hold
300,000
– – ﹤0.01% 612
2026
Q1 		$330K Hold
300,000
– – ﹤0.01% 596
2025
Q4 		$360K Hold
300,000
– – ﹤0.01% 567
2025
Q3 		$369K Hold
300,000
– – ﹤0.01% 566
2025
Q2 		$303K Hold
300,000
– – ﹤0.01% 533
2025
Q1 		$453K Hold
300,000
– – ﹤0.01% 471
2024
Q4 		$870K Hold
300,000
– – ﹤0.01% 501
2024
Q3 		$1.04M Hold
300,000
– – 0.01% 459
2024
Q2 		$1.16M Buy
300,000
+50,000
+20% +$478K 0.01% 455
2024
Q1 		$3.56M Buy
+250,000
New +$3.56M 0.02% 351

Other funds holding BOLD

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Alyeska Investment Group's BOLD Position: Q2 2026 in Review

Alyeska Investment Group held its Boundless Bio (BOLD) position steady in Q2 2026 at 300,000 shares worth $750K. The position accounts for ﹤0.01% of the portfolio, ranked #612.

Alyeska Investment Group first reported a position in BOLD in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.56M in Q1 2024. 40 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

  • Alyeska Investment Group held 300,000 shares of Boundless Bio worth $750K as of Q2 2026.
  • Alyeska Investment Group left its Boundless Bio share count unchanged in Q2 2026.
  • Boundless Bio made up ﹤0.01% of Alyeska Investment Group's portfolio in Q2 2026, its #612 holding.
  • Alyeska Investment Group first reported a position in Boundless Bio in Q1 2024 and has held it in 10 quarters since.
  • Alyeska Investment Group's Boundless Bio position peaked at $3.56M in Q1 2024.
  • 40 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.